Overview

Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents

Status:
Completed
Trial end date:
2009-02-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the pharmacokinetic parameters of chlorpheniramine in children and adolescents.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Chlorpheniramine
Maleic acid